Shattuck Labs (STTK) News Today $1.19 -0.05 (-4.03%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$1.20 +0.01 (+0.76%) As of 03/25/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Shattuck Labs, Inc. (NASDAQ:STTK) Given Consensus Rating of "Moderate Buy" by AnalystsMarch 22, 2025 | americanbankingnews.comLeerink Partnrs Comments on Shattuck Labs FY2024 EarningsShattuck Labs, Inc. (NASDAQ:STTK - Free Report) - Equities researchers at Leerink Partnrs issued their FY2024 EPS estimates for shares of Shattuck Labs in a research note issued on Monday, March 17th. Leerink Partnrs analyst F. Khurshid forecasts that the company will post earnings of ($1.42) perMarch 21, 2025 | marketbeat.comLeerink Partnrs Estimates Shattuck Labs FY2024 EarningsMarch 21, 2025 | americanbankingnews.comShattuck Labs (NASDAQ:STTK) Upgraded at Leerink PartnrsLeerink Partnrs raised Shattuck Labs to a "strong-buy" rating in a report on Monday.March 20, 2025 | marketbeat.comShattuck Labs (NASDAQ:STTK) Stock Rating Upgraded by Leerink PartnrsMarch 20, 2025 | americanbankingnews.comLeerink Partners Initiates Coverage on Shattuck Labs (NASDAQ:STTK)March 19, 2025 | americanbankingnews.comShattuck Labs, Inc. (NASDAQ:STTK) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Shattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six research firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation, one has issued a buy recommendatiMarch 18, 2025 | marketbeat.comShattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at Leerink PartnersLeerink Partners began coverage on shares of Shattuck Labs in a research note on Monday. They issued an "outperform" rating and a $4.00 target price for the company.March 18, 2025 | marketbeat.comLeerink Partners Initiates Coverage of Shattuck Labs (STTK) with Outperform RecommendationMarch 18, 2025 | msn.comShattuck Labs initiated with an Outperform at LeerinkMarch 17, 2025 | markets.businessinsider.comFavourable Signals For Shattuck Labs: Numerous Insiders Acquired StockMarch 11, 2025 | finance.yahoo.comShattuck Labs (STTK) to Release Earnings on ThursdayShattuck Labs (NASDAQ:STTK) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comH.C. Wainwright Keeps Their Hold Rating on Shattuck Labs (STTK)February 21, 2025 | markets.businessinsider.comShattuck Labs’ SL-325 shows positive results in inflammatory bowel diseaseFebruary 20, 2025 | markets.businessinsider.comShattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025February 20, 2025 | globenewswire.comShattuck Labs (STTK) Expected to Announce Earnings on WednesdayShattuck Labs (NASDAQ:STTK) will be releasing earnings on Wednesday, February 26.February 19, 2025 | marketbeat.comShattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025February 13, 2025 | globenewswire.comShattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis CongressFebruary 4, 2025 | markets.businessinsider.comShattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis CongressFebruary 4, 2025 | globenewswire.comShattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | globenewswire.comShattuck Labs highlights upcoming key milestones in 2025January 3, 2025 | markets.businessinsider.comShattuck Labs, Inc. Provides Corporate Update and Key Milestones for 2025January 2, 2025 | quiverquant.comShattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025January 2, 2025 | globenewswire.comShattuck Labs, Inc. (NASDAQ:STTK) Director Redmile Group, Llc Buys 133,371 SharesDecember 7, 2024 | insidertrades.comShattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in StockShattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) Director Redmile Group, Llc purchased 133,371 shares of the firm's stock in a transaction on Wednesday, December 4th. The stock was bought at an average price of $1.25 per share, with a total value of $166,713.75. Following the acquisition, the director now owns 5,539,724 shares in the company, valued at $6,924,655. This trade represents a 2.47 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.December 6, 2024 | marketbeat.comShattuck Labs Focuses on Promising Antibody DevelopmentNovember 19, 2024 | markets.businessinsider.comHC Wainwright Lowers Earnings Estimates for Shattuck LabsShattuck Labs, Inc. (NASDAQ:STTK - Free Report) - Research analysts at HC Wainwright decreased their FY2024 EPS estimates for shares of Shattuck Labs in a research report issued on Thursday, November 14th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per sharNovember 18, 2024 | marketbeat.comShattuck Labs: Navigating Strategic Shift to Autoimmune Pipeline Amidst Financial Stability and Hold RatingNovember 15, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Shattuck Labs (STTK)November 15, 2024 | markets.businessinsider.comShattuck Labs' (STTK) Neutral Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "neutral" rating on shares of Shattuck Labs in a report on Friday.November 15, 2024 | marketbeat.comShattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 14, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTKNovember 10, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTKNovember 2, 2024 | prnewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 28, 2024 | businesswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 27, 2024 | globenewswire.comShattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in OctoberShattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 2,180,000 shares, a drop of 60.0% from the September 30th total of 5,450,000 shares. Based on an average daily volume of 555,700 shares, the short-interest ratio is currently 3.9 days. Currently, 5.3% of the shares of the company are sold short.October 26, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTKOctober 25, 2024 | prnewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 21, 2024 | globenewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 16, 2024 | prnewswire.comSTTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the FirmOctober 15, 2024 | globenewswire.comShattuck Labs, Inc. (NASDAQ:STTK) CEO Taylor Schreiber Buys 36,500 SharesOctober 9, 2024 | insidertrades.comShattuck Labs, Inc. (NASDAQ:STTK) CEO Purchases $44,165.00 in StockShattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) CEO Taylor Schreiber bought 36,500 shares of the business's stock in a transaction on Monday, October 7th. The shares were acquired at an average price of $1.21 per share, with a total value of $44,165.00. Following the transaction, the chief executive officer now owns 71,002 shares of the company's stock, valued at $85,912.42. The trade was a 100.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.October 8, 2024 | marketbeat.comKaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Shattuck Labs, Inc. (STTK)October 4, 2024 | theglobeandmail.comNeedham Downgrades Shattuck Labs (STTK)October 4, 2024 | msn.comHC Wainwright Comments on Shattuck Labs, Inc.'s Q3 2024 Earnings (NASDAQ:STTK)Shattuck Labs, Inc. (NASDAQ:STTK - Free Report) - Research analysts at HC Wainwright raised their Q3 2024 EPS estimates for shares of Shattuck Labs in a note issued to investors on Tuesday, October 1st. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per shaOctober 3, 2024 | marketbeat.comHC Wainwright & Co. Downgrades Shattuck Labs (STTK)October 3, 2024 | msn.comShattuck cut to Neutral at Citi on program exitOctober 3, 2024 | seekingalpha.comShattuck Labs (NASDAQ:STTK) Downgraded to "Neutral" at CitigroupCitigroup downgraded Shattuck Labs from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $8.00 to $2.00 in a report on Wednesday.October 2, 2024 | marketbeat.comShattuck Labs (NASDAQ:STTK) Stock, Short Interest ReportOctober 2, 2024 | benzinga.comShattuck Labs Refocuses Strategy Amidst Restructuring and CutsOctober 2, 2024 | finance.yahoo.com Remove Ads Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address STTK Media Mentions By Week STTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STTK News Sentiment▼0.830.77▲Average Medical News Sentiment STTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STTK Articles This Week▼92▲STTK Articles Average Week Remove Ads Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies enGene News Today Foghorn Therapeutics News Today Y-mAbs Therapeutics News Today Nuvectis Pharma News Today Monopar Therapeutics News Today Korro Bio News Today INmune Bio News Today Tevogen Bio News Today Voyager Therapeutics News Today Eledon Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STTK) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
